Contracts for Innovation in drug and alcohol addiction healthcare

[{"label":"Substances in Scope","value":"Opioids. Stimulants including cocaine and methamphetamine. Cannabis. GHB. Ketamine. Benzodiazepines. Gabapentinoids."},{"label":"R&D Requirement","value":"At least 50% of contract value must be directly attributed to R&D services."},{"label":"Ineligible R&D Activities","value":"Quantity production. Commercial supply to recover R&D costs. Incremental improvements to existing products."},{"label":"VAT Rules","value":"VAT status must be declared. Costs must be entered exclusive of VAT. VAT responsibility lies with invoicing business. Total eligible costs inclusive of VAT must not exceed limits."},{"label":"Payment Structure","value":"Monthly payments in arrears against completed milestones. No advance payments. Invoices must be submitted within 30 days of each claim period."},{"label":"Intellectual Property","value":"Applicant retains foreground and background IP. Must grant certain royalty free licences to funder."},{"label":"Commercialisation Requirement","value":"Must demonstrate credible UK route to market. Must include commercial plan and financial projections."},{"label":"Subsidy Control","value":"Procurement under the Procurement Act 2023 R&D exemption. Not subject to subsidy control criteria."},{"label":"Sanctions Rule","value":"Funding will not be provided where it breaches UK sanctions."},{"label":"Animal Research Rule","value":"Projects involving animals must comply with UKRI animal welfare guidance."},{"label":"Key Requirements","value":"Must engage people with lived experience. Must engage treatment or service providers. Must define regulatory pathway. Must complete business model. Must align with national addiction strategies."},{"label":"Renewal Rules","value":"Not specified"},{"label":"Important Notes","value":"Single phase competition. Cannot apply to both strands with same project. Project must not start before contract approval. Milestones must be SMART and linked to payments. Funding subject to sufficient high quality applications."}]